Moloney Securities Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.59M Sell
3,277
-902
-22% -$420K 0.19% 130
2025
Q2
$1.69M Buy
4,179
+632
+18% +$264K 0.21% 118
2025
Q1
$1.76M Buy
3,547
+1,028
+41% +$557K 0.24% 100
2024
Q4
$1.31M Sell
2,519
-55
-2% -$30.2K 0.18% 145
2024
Q3
$1.59M Buy
2,574
+224
+10% +$133K 0.21% 116
2024
Q2
$1.3M Sell
2,350
-60
-2% -$34.4K 0.19% 132
2024
Q1
$1.4M Buy
2,410
+33
+1% +$18.5K 0.21% 120
2023
Q4
$1.26M Buy
2,377
+138
+6% +$66.8K 0.2% 124
2023
Q3
$1.13M Buy
2,239
+486
+28% +$259K 0.2% 119
2023
Q2
$915K Buy
1,753
+44
+3% +$23.7K 0.16% 151
2023
Q1
$985K Buy
1,709
+7
+0.4% +$3.94K 0.18% 142
2022
Q4
$937K Sell
1,702
-144
-8% -$76.3K 0.21% 133
2022
Q3
$936K Sell
1,846
-19
-1% -$10.6K 0.23% 120
2022
Q2
$1.01M Sell
1,865
-56
-3% -$30.8K 0.24% 121
2022
Q1
$1.14M Sell
1,921
-129
-6% -$74.1K 0.22% 125
2021
Q4
$1.37M Sell
2,050
-2,028
-50% -$1.27M 0.23% 107
2021
Q3
$2.33M Buy
4,078
+707
+21% +$388K 0.42% 66
2021
Q2
$1.7M Buy
3,371
+369
+12% +$174K 0.31% 90
2021
Q1
$1.37M Buy
3,002
+169
+6% +$80.7K 0.27% 99
2020
Q4
$1.32M Sell
2,833
-33
-1% -$15.5K 0.29% 89
2020
Q3
$1.26M Sell
2,866
-54
-2% -$22.3K 0.33% 85
2020
Q2
$1.06M Sell
2,920
-44
-1% -$14.7K 0.31% 96
2020
Q1
$841K Buy
2,964
+331
+13% +$104K 0.3% 99
2019
Q4
$855K Sell
2,633
-216
-8% -$65.5K 0.26% 114
2019
Q3
$830K Sell
2,849
-149
-5% -$42.7K 0.28% 107
2019
Q2
$880K Sell
2,998
-137
-4% -$37.7K 0.29% 103
2019
Q1
$858K Sell
3,135
-6
-0.2% -$1.49K 0.3% 110
2018
Q4
$703K Sell
3,141
-965
-24% -$226K 0.29% 107
2018
Q3
$1M Buy
+4,106
New +$945K 0.35% 92

Other funds holding TMO

Moloney Securities Asset Management's TMO Position: Q3 2025 in Review

Moloney Securities Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 22% in Q3 2025, selling an estimated $420K and leaving 3,277 shares worth $1.59M. The position accounts for 0.19% of the portfolio, ranked #130.

Moloney Securities Asset Management first reported a position in TMO in Q3 2018 and has held it in 29 quarters since. The position peaked at $2.33M in Q3 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Moloney Securities Asset Management held 3,277 shares of Thermo Fisher Scientific worth $1.59M as of Q3 2025.
  • Moloney Securities Asset Management sold 902 Thermo Fisher Scientific shares in Q3 2025, an estimated $420K.
  • Thermo Fisher Scientific made up 0.19% of Moloney Securities Asset Management's portfolio in Q3 2025, its #130 holding.
  • Moloney Securities Asset Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 29 quarters since.
  • Moloney Securities Asset Management's Thermo Fisher Scientific position peaked at $2.33M in Q3 2021.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.